/ Print /

Pharmacy

Opioid crisis legal ramifications: How to protect your healthcare organizationOverprescribing by just one practitioner can lead to an untoward outcome that may readily affect the entire healthcare facility.
How one project will change the way value is measured in healthcareThe Innovation and Value Initiative's Mark Linthicum talks to Managed Healthcare Executive (MHE) a new tool to better measure value in healthcare treatments.
New patient-centered tool could help measure value in healthcareThe Innovation and Value Initiative launched the Open-Source Value Project, creating tools that help payers, providers, and healthcare systems make informed and patient-centered decisions that produce better health outcomes.
Healthcare leaders must step up to fix the opioid epidemicHealthcare executives have a unique leadership role to play in addressing the opioid crisis. Here’s what you need to do now.
Is there a simple fix for the Part D discount program?A poll from the Biosimilars Council, a division of the Association for Accessible Medicines, has interesting findings about placing biosimilars and branded biologics on a level playing field to save money.
New RA drugs and pipeline developments to watchTreating RA is a work in progress. Here’s what you need to know.
Kentucky opioid program drops dispensing by 50%Howard Shaps, MD, senior medical director, WellCare of Kentucky, shares details about the Medicaid insurers’ pilot program designed to fight the opioid epidemic.
Six healthcare marketing trends for 2018Here are six healthcare impact trends that will challenge marketers in the upcoming year.
How treating opioid use disorder is cost effectiveA commercial health plan analysis by axialHealthcare has interesting findings about funding opioid use disorder treatment plans.
ICER-VA alliance for formulary management sparks debateThe National Pharmaceutical Council takes issue with ICER’s collaboration with the VA’s PBM. Find out what both camps are saying.